Iron deficiency, a condition currently affecting ;3 billion people, persists in the 21st century despite half a millennium of medical treatment. Soybean ferritin (SBFn), a large, stable protein nanocage around a mineral with hundreds of iron and oxygen atoms, is a source of nutritional iron with an unknown mechanism for intestinal absorption. Iron absorption from SBFn is insensitive to phytate, suggesting an absorption mechanism different from for the ferrous transport. Here, we investigated the mechanism of iron absorption from mineralized SBFn using Caco-2 cells (polarized in bicameral inserts) as an intestinal cell mode and analyzed binding, internalization and degradation with labeled SBFn ( 131 I or fluorescent labels), confocal microscopy, and immunoanalyses to show: 1) saturable binding to the apical cell surface; dissociation constant of 7.75 6 0.88 nmol/L; 2) internalization of SBFn that was dependent on temperature, concentration, and time; 3 ) entrance of SBFn iron into the labile iron pool (calcein quenching); 4) degradation of the SBFn protein cage; and 5 ) assembly peptide 2 (AP2)-/clathrin-dependent endocytosis (sensitivity of SBFn uptake to hyperosmolarity, acidity, and RNA interference to the m 2 subunit of AP2), and resistance to filipin, a caveolar endocytosis inhibitor. The results support a model of SBFn endocytosis through the apical cell membrane, followed by protein cage degradation, mineral reduction/dissolution, and iron entry to the cytosolic iron pool. The large number of iron atoms in SBFn makes iron transport across the cell membrane a much more efficient event for SBFn than for single iron atoms as heme or ferrous ions.
Introduction
Cells transport nutrient iron from foods by mechanisms related to the type of iron complex, such as endocytosis for Fe-transferrin from blood and, in the gut, membrane transporters such as heme carrier protein 1 (HCP1) 7 for heme (myoglobin) (1) and divalent metal transporter 1 (DMT1) for ferrous and other divalent cations (2) (3) (4) (5) . Current data indicate that after internalization, iron from heme or inorganic sources becomes part of the cytosolic labile iron pool (LIP) [reviewed in (6) ] and is either concentrated and stored in ferritin or moved to the basolateral membrane for efflux; this latter process is dependent on the iron-export transporter ferroportin, also known as Iron Regulated Gene 1 (7) (8) (9) , in combination with the ferrous oxidase hephaestin (10) .
Recent studies show that ferritin iron, a biomineral inside a large stable protein nanocage, can be absorbed from foods such as legumes, a particularly rich source [reviewed in (11, 12) ]. The cellular mechanism used to absorb ferritin iron is unknown, but because ferritin is a very stable protein (13, 14) and ferritin iron can be absorbed from soybean ferritin (SBFn) even in the presence of iron-binding inhibitors such as phytate (15) , it is possible that the mechanism differs from that used to transport lower molecular weight iron complexes. High-affinity mammalian ferritin binding sites have been reported in reticulocytes, lipocytes, hepatocytes, placenta, brain, and kidney (16) (17) (18) (19) , although the mechanism of ferritin endocytosis has not been elucidated. We investigated possible mechanisms of ferritin uptake using fluorescence microscopy, calcein quenching, and 131 I-SBFn binding, uptake, and degradation assays in the intestinal epithelial cell line, Caco-2, as a model for polarized epithelial cells.
Materials and Methods

Ferritin protein
SBFn was isolated from the clarified supernatant fractions as we previously described (20) using chromatography on DEAE-Sephadex and Sephacryl S300. SBFn purity was evaluated by electrophoresis in both SDS and native gels, calibrated with molecular weight markers, and stained with Coomassie Blue. Purity was .90%. The isolated protein also reacted with SBFn antiserum followed by incubation with horseradish peroxidase-conjugated anti-rabbit IgG and a peroxidase-based chemiluminescence assay kit (ECL1, Bio-Rad).The iron content of a typical preparation was 450 Fe per protein nanocage. Purified protein was stored at 4°C in 0.2 mol/L MOPS, 0.2 mol/L NaCl, pH 7.0, or frozen at -20°C in 20% glycerol.
I-labeling of SBFn
SBFn was labeled with 131 I (5 mCi/mg protein) using the Iodogen reagent (Pierce Chemical). After iodination, 131 I-labeled SBFn was separated from free 131 I by 50% ammonium sulfate precipitation followed by extensive dialysis against saline containing the anionic resin AG1 38 (Bio-Rad) to eliminate adventitiously bound 131 I. 131 I-labeled SBFn was stored at 4°C and used within 10 d after labeling.
Binding of
131 I-labeled SBFn and horse spleen ferritin to Caco-2 cells Human Caco-2 cells (ATCC HTB37) grown on plastic wells for 12-14 d in DMEM supplemented with 10% fetal bovine serum were incubated in serum-free DMEM with concentrations of 131 I-labeled SBFn or horse spleen ferritin (HSFn) that varied between 1 and 40 nmol/L, with or without the addition of 100-fold excess unlabeled ferritin. Binding was performed for 2 h at 4°C. Cells were washed 5 times with ice-cold PBS and detached from the plates with 200 mL 40 mmol/L Tris-HCl, pH 7.4, 100 mmol/L NaCl, 1 mmol/L EDTA for 10 min and then collected by centrifugation at 390 3 g; 5 min (Hettich Mikro 22R centrifuge). Cellassociated 131 I radioactivity was determined in a Cobra II Gamma Radioactivity Counting System (Packard). An aliquot of the cell suspension was used for protein determination with bicinchoninic acid (21) . Each data point was determined in triplicate. Specific binding was calculated by subtracting binding of 131 I-labeled SBFn or HSFn in the presence of an excess of the corresponding unlabeled ferritin, from binding in the absence of excess, unlabeled SBFn. Binding data were analyzed using GraphPad Prism software (GraphPad Software). I-SBFn degradation products, the incubation medium was precipitated for 30 min on ice with 10% trichloroacetic acid (TCA). Then 10 mL of FBS was added as carrier protein to obtain a visible pellet. The mixture was separated into precipitate and supernatant fractions by centrifugation at 9860 3 g; 5 min in a Mikro 22R centrifuge. Radioactivity in the supernatant and precipitated fractions of the culture medium represented degraded and nondegraded 131 I-SBFn, respectively (22) (23) (24) .
Inhibition of SBFn endocytosis
Caco-2 cells grown in Transwell inserts were incubated for 60 min at 37°C with 5 nmol/L 131 I-SBFn in the following media: DMEM (control); DMEM plus 5 mg/L Filipin III (Sigma); DMEM plus 0.45 mol/L sucrose (hypertonic), and DMEM with 10 mmol/L acetic acid (cytosol acidification). The cells were washed and surface-bound ferritin was displaced by an overnight incubation at 4°C with 500 nmol/L SBFn. The remaining cell-associated 131 I radioactivity represented intact, internalized SBFn.
Confocal microscopy
Fluorescent reporter linked to secondary antibody. SBFn (5 nmol/L) was added to polarized Caco-2 cells grown on glass cover slips followed by incubation for 60 min. Cells were then fixed and permeabilized, blocked, and incubated overnight with anti-SBFn rabbit antiserum cells) were treated with 2.5 mg DNA in lipofectamine (Gibco) for 36 h at 37°C as previously described (26); transfection efficiencies were 20-25%. Lipofectamine-transfected cells were used for immunocytochemistry of m 2 .
Electroporation. Caco-2 cells grown as above were nucleofected with pSUPER containing the m2 target sequence using a Nucleofector device and the Caco-2 transfection kit following the manufacturer's protocol (amaxa GmbH). Nucleofected cells, 3-4 d after transfection when the transfection efficiency was ;65-75%, were analyzed for SBFn internalization and m 2 protein expression (Western blot).
Western blot analysis of m 2
Cell extracts from control and m 2 -electroporated cells were prepared by treating cells with lysis buffer [50 mL/1 3 10 6 cells of 10 mmol/L MOPS, pH 7.5, 3 mmol/L MgCl 2 , 40 mmol/L KCl, 1 mmol/L phenylmethylsulfonyl fluoride, 10 mg/L leupeptin, 0.5 mg/L aprotinin, 0.7 mg/L pepstatin A, 5% glycerol, 1 mmol/L dithiothreitol, 0.1% Triton X-100]. The mixture was incubated for 15 min on ice and then fractionated by centrifugation at 5000 3 g; 10 min. Protein concentrations were determined using the bicinchoninic acid protein assay. The supernatant fraction was stored at 270°C (27) . For Western blotting, samples containing 100 mg of protein were boiled in Laemmli sample buffer for 5 min and the denatured proteins resolved by SDS-PAGE (10% acrylamide). Proteins were transferred to nitrocellulose membrane and blocked for 1 h at 25°C with 5% nonfat dry milk in blocking saline [20 mmol/L Tris, 0.5 mol/L NaCl, 0.05% (wt:v) Tween-20]. Membranes were incubated overnight at 4°C with anti-m 2 at a 1:200 dilution, rinsed with blocking saline, and incubated with horseradish peroxidase-conjugated anti-mouse IgG for 1 h at 25°C. A chemiluminescence assay kit was used for detection (SuperSignal, Pierce Chemical). Chemiluminescence was detected with Fuji photographic film and the band density was determined with the Quantity One (Bio-Rad) program.
Determination of iron incorporation with calcein
Polarized Caco-2 cells grown in 2-cm tissue culture wells were incubated for 15 min at 37°C in Hanks' Balanced salt solution containing 5 mmol/L glucose and 1 mmol/L calcein as the lipophilic, acetoxymethyl ester calcein-AM (Invitrogen-Molecular Probes). Calcein-AM is hydrolyzed by intracellular esterases to the membrane-impermeable calcein. The decreased calcein fluorescence (485 nm excitation, 530 nm emission) after adding SBFn or ferrous ammonium sulfate (FAS) was quantified using a Cytofluor II plate reader (Applied Biosystems). After stabilization of the background calcein fluorescence in cells, the medium was supplemented with either 10 nmol/L SBFn or 10 mmol/L FAS and changes in calcein fluorescence were monitored for the next 20 min. Calcein photobleaching was measured in control cells incubated in parallel. Typically, at the end of 20 min, calcein photobleaching was ,2% of the initial calcein fluorescence. To eliminate possible interference from nonmineral iron, SBFn was treated with 10 mmol/L diethylenetriaminepentaacetic acid and dialyzed against DMEM prior to the experiment.
Statistical analysis
The data presented are triplicate analyses from 2 or more independent experiments. Experimental variability was ,20%. One-way ANOVA was used to test for significant differences among mean values and Tukey's post hoc test was used for comparisons (InStat, GraphPad Software). Differences were considered significant if P , 0.05.
Results
SBFn protein binding, internalization, and degradation by Caco-2 cells. Apical internalization of SBFn was demonstrated by immunofluorescence using an antibody specific for SBFn (Fig. 1) ; SBFn polypeptides .10 kDa are immunoreactive (22) . Overlays of fluorescence and phase contrast images from cells, incubated without or with SBFn prior to immunodetection, showed the specificity of anti-SBFn (Fig. 1A) . There was a gradient of decreasing immunoreactivity as the distance from the apical surface of the cell increased, with most of the reactivity in the apical half of the cells (Fig. 1B,C) .
Specific binding of SBFn to the apical surface of Caco-2 cells. To determine the properties of SBFn interactions with the apical membrane of Caco-2 cells, we analyzed binding of SBFn labeled with 131 I to the apical membrane Caco-2 cells (Fig. 2) . Binding of 131 I-labeled HSFn was also determined. Nonspecific binding, determined as the 131 I radioactivity remaining after incubation in the presence of unlabeled SBFn (100-fold excess), was subtracted from total 131 I radioactivity. Nonspecific binding The amount of 131 I in the medium after 1 h of incubation was equivalent to 130.3 6 15.6 fmol/mg protein compared with 10.0 6 1.4 fmol/mg protein of intact 131 I-SBFn inside the cells (Fig. 3B) . These values indicate that SBFn was degraded quickly after internalization and the degradation products were released into the medium. Moreover, actively metabolizing cells were necessary to convert the internalized 131 I-SBFn to TCA-soluble 131 I in the medium, because incubation with or without cells at 4°C, or without cells at 37°C, converted only ;5% of the 131 I-SBFn to TCA-soluble fragments (Fig. 3C) .
Fate of the iron in internalized SBFn. A measure of the biological availability of absorbed ferritin iron is entry into the LIP, which corresponds to iron bound with low affinity to a variety of cytosolic ligands (29) . To determine whether ferritin iron becomes available to the cell cytoplasm when the mineralized protein is internalized by Caco-2 cells, we measured calcein fluorescence, which is quenched upon binding either Fe 12 or Fe 13 (30, 31) . Calcein fluorescence decreased with time when either mineralized HSFn or mineralized SBFn was used as the iron source, indicating that iron from either source entered the cytosolic LIP (Fig. 4A) . Desferal did not inhibit iron incorporation from HSFn, an indication that HSFn did not have adventitious iron. FAS iron, which enters cells via the DMT1 transporter, was used as a positive control (32) and the fluorescence of cell calcein without added iron was followed to assess calcein photobleaching during the experiment. As a negative control, the iron-donating capacity of apoSBFn was determined. No changes in calcein fluorescence were observed with apoSBFn (data not shown). Changes in calcein fluorescence were best fit to a 1-phase, exponential decay model. The steady state in calcein quenching probably reflects a balance between iron influx into the cytosol and iron traffic to other subcellular compartments.
Because previous studies have detected surface ferritin receptors (16) (17) (18) (19) and because the size of ferritin would require endocytosis as a cellular internalization process, we tested the effects of interfering with clathrin-coated pit function on the entry of ferritin iron into the LIP. Interference with normal clathrincoated vesicles was achieved by cytoplasmic acidification, which interferes with budding of clathrin-coated vesicles from the plasma membrane and by incubation in hypertonic medium, which prevents clathrin and AP2 from interacting (33) (34) (35) (Fig. 4B) .
The effect of SBFn concentration on the LIP was also determined (Fig. 4C,D) . Increased SBFn concentration resulted in increased initial rates of calcein quenching, which reached a plateau (Fig. 4C) (Fig. 4D) , a clear indication that most of the mineralized iron from SBFn or HSFn that was specifically bound to the cell was available to the LIP.
Inhibition of SBFn internalization by acidification and hyperosmolarity and insensitivity of internalization to filipin. To further investigate the pathway(s) of SBFn protein internalization in human intestinal epithelial Caco-2 cells, we examined the subcellular distribution of SBFn labeled with Oregon Green after incubation for different periods of time (Fig.  5A) . After a 5-min incubation with Oregon-green-ferritin, most of the label was at the apical membrane, as it was for the fluorescent immunoanalysis (Fig. 1) . However, after longer periods of incubation, an apical-to-basal gradient of the label was observed (Fig. 5) , with intracellular fluorescence increasing up to 30 min, when signals in the apical, cytosolic, and basal domains were evident, a contrast with the immunofluorescent analysis (Fig. 1) . The signal from Oregon green-labeled SBFn on the basal side of the cell likely indicates degraded SBFn fragments that remain linked to Oregon Green and suggests that internalized SBFn is degraded in an apical-to-basal direction. Effects of inhibitors of caveolar-or clathrin-dependent endocytosis of Oregon green-SBFn ferritin were studied by preincubating cells with inhibitors and analyzing the effect either on the distribution of Oregon Green-labeled SBFn (Fig. 5 A,B) or on uptake of 131 I-labeled SBFn (Fig. 5C ). Inhibitors of clathrinmediated endocytosis (hypertonicity or cytosol acidification) changed the distribution of Oregon Green fluorescence, which was concentrated at the apical limit contrasting with control cells fluorescence (Fig. 5B) . Filipin, a sterol-binding agent that disrupts cholesterol microdomains in caveolae but does not influence clathrin-dependent endocytosis (36-38), did not affect SBFn internalization (Fig. 5B) ; the slight decrease in retention of the labeling in the apical membrane of filipin-treated cells likely reflects the impact of Filipin on the membrane structure. Inhibitors of clathrin-dependent endocytosis had similar effects on 131 I-labeled SBFn internalization, which was also resistant to filipin (Fig. 5C ). The inhibitor data (Fig. 5) , combined with those from the calcein study (Fig. 4) , indicate that both Fe transfer from SBFn to the LIP and SBFn protein internalization depend on an AP2-mediated pathway.
Inhibition of SBFn internalization by RNA interference of m 2 , a subunit of the AP2 complex. More direct data for the dependence of SBFn uptake on AP2 was sought with RNA interference for the m 2 subunit of the AP2 endocytic complex (Fig. 6) . Western blot analysis of transfected cells revealed decreased expression of the m 2 protein (Fig. 6A ), which correlated with decreased intracellular SBFn, i.e. decreased 131 I-labeled SBFn uptake (Fig. 6B) . IgG uptake by intestinal cells, which depends on by clathrin-mediated endocytosis (39, 40) , was also inhibited by m 2 RNA interference (Fig. 6B) . The sensitivity of ferritin and IgG internalization to m 2 expression supports the hypothesis that ferritin uptake is facilitated by an AP2-mediated endocytosis pathway.
Discussion
Recent studies show that ferritin iron is absorbed by mammals from plant ferritin [reviewed in (12) ]. This observation is potentially important for the treatment of iron deficiency anemia, a condition affecting ;3 billion people in the 21st century despite half a millennium of medical diagnoses and treatments. Moreover, the difference in the structure of ferritin iron, a solid mineral of hundreds to thousands of atoms inside a large, hydrophilic protein cage, compared with the single iron atoms in lipid-soluble heme or the single ferrous ion coordinated to 6 water molecules raises the possibility that ferritin is recognized by different molecules on the surface of intestinal cells compared with the more extensively studied forms of iron in heme and ferrous salts. All cells synthesize ferritin, the spherical, protein nanocages with iron biominerals inside, at some time during differentiation or maturation (41) . In animal cells, in addition to the generic Fer H-type gene found universally in animals, plants and bacteria, a catalytically inactive subunit, FerL, is expressed that coassembles with the FerH subunit in variable amounts (42, 43) , making endogenous intestinal cell ferritin different from plant ferritin. Each plant ferritin subunit also has a distinctive N-terminal extension (20) .
In this study, we showed that SBFn entered cells from the apical surface of Caco-2 cells by an AP2-mediated endocytic pathway. Based on the calcein fluorescence quenching data, once internalized, SBFn iron entered the common intracellular iron pool, indicating the physiological relevance of ferritin uptake, and the SBFn protein was degraded, as demonstrated by the release of 131 I into the TCA-soluble fraction of the medium. Because steady-state SBFn binding occurs later (;30 min) than calcein quenching (1-2 min) (Figs. 3,4) , the data do not distinguish among iron release before protein degradation from intact molecules (43) or after protein degradation (12) or both. Thus, gut absorption of plant ferritin via ferritin endocytosis could provide iron for bodily needs and may explain the presence of ferritin-rich legumes among the earliest plants domesticated by humans (44) .
Endocytosis of iron as the ferritin mineral is much more efficient transport event than transport of individual iron atoms across the cell membrane as ferrous iron via DMT1 or heme via HCP1, e.g., as the ferritin mineral usually contains hundreds to thousands of iron atoms (42, 43) . As found in nature, the SBFn used in this study was only partly filled with mineral (20) and contained an average of 450 ferric atoms. Therefore, in only 1 endocytosis event, a SBFn molecule releases to the cytosol an amount of iron equivalent to 450 iron-transport events through DMT1. Ferritin uptake has been observed in liver hepatocytes (47) , lipocytes (18) , erythroid precursors (28), mouse brain (19) , and placental microvilli membrane (16) . The finding that Ig-domain and mucin-domain protein 1 in kidney and liver is a specific receptor for endogenous H-ferritin in mouse (17) complemented earlier studies of saturable cell surface sites as participants in ferritin uptake. In addition, the suggestion of gut iron resorption from endogenous ferritin released during enterocyte turnover (48) could depend on ferritin/cell surface interactions. Regulation of ferritin uptake by cellular iron status has been observed for some cell types, such as erythroid precursors and cells in the placental microvilli (16, 28) , but iron regulation is absent in liver hepatocytes (47) , possibly because of the specialized role of hepatocytes in storing excess body iron. Ferritin uptake by endocytosis through the apical membrane of Caco-2 cells is an extremely efficient uptake of iron through the cascade of ferritin internalization, mineral dissolution, and iron release.
Current molecular knowledge of cellular iron transport is limited to entry of ferrous ions (DMT1) or heme (HCP1) on the apical surface and the release of ferrous via ferroportin at the basolateral surface of gut absorptive epithelial cells. How iron moves from one side of the cell to the other, and where, and/or whether the 2 pathways converge within the cell have remained a mystery. SBFn endocytosis, identified here in intestinal Caco-2 cells, easily distinguished immunologically from endogenous ferritin, may be a valuable tool for tracking iron across cells, identifying the point(s) of convergence in trafficking of the different iron complexes entering cells by different pathways, and for a more complete understanding of iron nutrition from different sources.
